Temporal alterations and cellular mechanisms of transmural repolarization during progression of mouse cardiac hypertrophy and failure

被引:25
作者
Shi, C. [1 ,2 ]
Wang, X. [3 ]
Dong, F. [1 ,2 ]
Wang, Y. [1 ,2 ]
Hui, J. [1 ,2 ]
Lin, Z. [1 ,2 ]
Yang, J. [1 ,2 ]
Xu, Y. [1 ,2 ]
机构
[1] Hebei Med Univ, Key Lab Neural & Vasc Biol, Minist Educ, Dept Pharmacol, Shijiazhuang 050017, Peoples R China
[2] Hebei Med Univ, Key Lab New Drug Pharmacol & Toxicol, Dept Pharmacol, Shijiazhuang 050017, Hebei Province, Peoples R China
[3] Hebei Med Univ, Hosp 3, Shijiazhuang 050017, Peoples R China
基金
中国国家自然科学基金;
关键词
cardiac hypertrophy; heart failure; L-type calcium channel; mouse; potassium channels; transmural dispersion of repolarization; RAT LEFT-VENTRICLE; K+ CURRENTS; MODEL; CA2+; EXPRESSION; CONDUCTION; DISPERSION; DEATH; ARRHYTHMOGENESIS; DEPOLARIZATION;
D O I
10.1111/apha.12071
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Aim The remodelling of transmural dispersion of repolarization (TDR) in human heart failure (HF) and in different animal models of cardiac hypertrophy or HF remains a controversial topic. We hypothesize that TDR may exhibit temporal alterations, depending on the stage of the disease. Methods We systematically investigated the temporal alterations of TDR during the development of cardiac hypertrophy and HF in the mouse pressure-overload model using electrophysiological and molecular biology techniques. Results A progressive prolongation of QT interval and changes in the amplitude of the J wave at 2, 5, 9 and 13 weeks were found in anesthetized aorta-banded mice. Action potential duration (APD) at 90% repolarization (APD90) in subendocardial myocytes of the left ventricular free wall remained unchanged at the hypertrophic stage (2 and 5weeks), but was significantly prolonged in HF mice at 9 and 13weeks. However, APD90 in subepicardial myocytes exhibited a significant prolongation at 2weeks and did not progressively extend from 2weeks to 13weeks in banded mice. Thus, non-parallel prolongation of APD in subendocardial and subepicardial myocytes led to a reduction in TDR at hypertrophic stage and an amplification of TDR at HF stage. Further experiments revealed that asynchronous down-regulation of voltage-dependent potassium currents (Ito,f, IK,slow and Iss) and L-type calcium currents (ICa-L) in subendocardial and subepicardial myocytes may contribute to the dynamic remodelling of transmural APD. Conclusion The two distinct TDR modes were revealed during the progression of mouse cardiac hypertrophy and failure, indicating that the remodelling of TDR depends on the stage of the disease.
引用
收藏
页码:95 / 110
页数:16
相关论文
共 50 条
  • [11] Subcompartments of the Nucleus are Differentially Modulated During the Development of Cardiac Hypertrophy and Failure in the Mouse
    Franklin, Sarah
    Mitchell-Jordan, Scherise
    Chen, Haodong
    Ren, Vincent
    Ping, Peipei
    Wang, Yibin
    Zhang, Michael
    Vondriska, Thomas M.
    CIRCULATION, 2010, 122 (21)
  • [12] Inhalation of diesel exhaust does not exacerbate cardiac hypertrophy or heart failure in two mouse models of cardiac hypertrophy
    Yonggang Liu
    Wei-Ming Chien
    Ivan O Medvedev
    Chad S Weldy
    Daniel L Luchtel
    Michael E Rosenfeld
    Michael T Chin
    Particle and Fibre Toxicology, 10
  • [13] Inhalation of diesel exhaust does not exacerbate cardiac hypertrophy or heart failure in two mouse models of cardiac hypertrophy
    Liu, Yonggang
    Chien, Wei-Ming
    Medvedev, Ivan O.
    Weldy, Chad S.
    Luchtel, Daniel L.
    Rosenfeld, Michael E.
    Chin, Michael T.
    PARTICLE AND FIBRE TOXICOLOGY, 2013, 10
  • [14] Structural remodeling of cardiac myocytes in hypertrophy and progression to failure
    Gerdes, AM
    Wang, XJ
    CARDIAC REMODELING AND FAILURE, 2003, 5 : 183 - 193
  • [15] MECHANISMS OF VENTRICULAR ARRHYTHMIAS IN CARDIAC-FAILURE AND HYPERTROPHY
    PYE, MP
    COBBE, SM
    CARDIOVASCULAR RESEARCH, 1992, 26 (08) : 740 - 750
  • [16] Finerenone Inhibits the Progression of Cardiac Hypertrophy in the HFpEF Mouse Model
    Morikawa, Kei
    Arima, Yuichiro
    Tsujita, Kenichi
    CIRCULATION, 2023, 148
  • [17] Comprehensive plasma and tissue profiling reveals systemic metabolic alterations in cardiac hypertrophy and failure
    Mueller, Oliver J.
    Heckmann, Markus B.
    Ding, Lin
    Rapti, Kleopatra
    Rangrez, Ashraf Y.
    Gerken, Thomas
    Christiansen, Nicole
    Rennefahrt, Ulrike E. E.
    Witt, Henning
    Maldonado, Sandra Gonzalez
    Ternes, Philipp
    Schwab, Dominic M.
    Ruf, Theresa
    Hille, Susanne
    Remes, Anca
    Jungmann, Andreas
    Weis, Tanja M.
    Kreusser, Julia S.
    Groene, Hermann-Josef
    Backs, Johannes
    Schatz, Philipp
    Katus, Hugo A.
    Frey, Norbert
    CARDIOVASCULAR RESEARCH, 2019, 115 (08) : 1296 - 1305
  • [18] Transcriptional, Post-Transcriptional, and Post-Translational Mechanisms Rewrite the Tubulin Code During Cardiac Hypertrophy and Failure
    Phyo, Sai Aung
    Uchida, Keita
    Chen, Christina Yingxian
    Caporizzo, Matthew A.
    Bedi, Kenneth
    Griffin, Joanna
    Margulies, Kenneth
    Prosser, Benjamin L.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [19] Ouabain prevents pathological cardiac hypertrophy and heart failure through activation of phosphoinositide 3-kinase a in mouse
    Wu, Jian
    Li, Daxiang
    Du, Lingling
    Baldawi, Mustafa
    Gable, Marjorie E.
    Askari, Amir
    Liu, Lijun
    CELL AND BIOSCIENCE, 2015, 5
  • [20] Molecular and cellular mechanisms of mechanical stress-induced cardiac hypertrophy
    Zou, YZ
    Takano, H
    Akazawa, H
    Nagai, T
    Mizukami, M
    Komuro, I
    ENDOCRINE JOURNAL, 2002, 49 (01) : 1 - 13